Edwards Lifesciences (EW) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 set for muted open after big bank earnings, chip slide weighs
- Oil eases as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Sysco calls on Teamsters to end LA strike after economic deal reached
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Edwards Lifesciences (EW) PT Lowered to $118 at Barclays on 3Q; 'Quarter Over Quarter Slowdown in U.S. TAVR Growth'
October 25, 2017 12:36 PM EDTBarclays lowered its price target on Edwards Lifesciences (NYSE: EW) to $118.00 (from $120.00) while maintaining a Equalweight rating, following the company's third quarter earnings report.
Analyst Matthew Taylor notes the company delivered third quarter earnings per share and revenue results below consensus projections, as... More
Edwards Lifesciences (EW) PT Lowered to $135 at Canaccord Genuity
October 25, 2017 5:33 AM EDTCanaccord Genuity lowered its price target on Edwards Lifesciences (NYSE: EW) to $135.00 (from $155.00) while maintaining a Buy rating.
Analyst Jason Mills remains positive on the stock noting LT TAVR & TMVR catalyst trump the negative NT trends and would be a buyer on weakness in the $100 range.
... More


